MedPath

Comparison of Erandamoola Distillate and Udavarta Roga Nashaka Distillate in Painful Menstruation.

Phase 2
Not yet recruiting
Conditions
Primary dysmenorrhea. Ayurveda Condition: UDAVARTINI,
Registration Number
CTRI/2025/03/082870
Lead Sponsor
Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital
Brief Summary

Primary dysmenorrhea is prevalentgynecological condition that affects a large proportion of woman and havesignificant impact on their quality of life. It is characterized by severelower abdominal pain and discomfort that can range from mild to debilitating.The pain is typically felt before or during menstruation and may be accompaniedby other symptoms such as nausea, headache and fatigue. In India the prevalencerate varies between 50-87.8%.

*Udavartini yonivyapad* is one among 20 *yonivyapad,* can be corelatedwith primary dysmenorrhea. *Nidana, samprapti* and *roopa* of *Udavartiniyonivyapad* can be well explained with etiopathogenesis and clinicalfeatures of primary dysmenorrhea. *Arthave sa vimukthe tu tat kshanam labhatesukham* substantiate the comparison of *Udavartini* with primarydysmenorrhea.Owing to *svaprakopaka nidana* such as *vegavadharana*and *vata prakopaka ahara vihara*, menstruation becomes painful in *Udavartini  yonivpad* due to *pratiloma gati* of *apanavata*.Previously numerous studies have been conducted for same condition on *shodanakarmas* mainly *basti* and other oral medications. *Arka kalpana*which is very unique form of medicine by its palatability, high potency andminimum dose, and is less explored form of medicine. *Erandamoola Arka*attributes to *vatahara* and *shoolahara* property which is selectedfor the present study and will be compared to *Udavarta Roga Nashaka Arka*,which is already proven to have significant results in management of primarydysmenorrhea.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • Subjects having spasmodic type of pain during menstruation which is confined to lower abdomen or radiates to back and medial aspects of thighs with or without associated symptoms like nausea, vomiting, fatigue, giddiness, constipation, headache and diarrhea.
  • Age between 18-40years.
  • Regular menstrual cycle.
  • Willing to sign the informed written consent form.
Exclusion Criteria
  • Known case of HIV, HBsAg, VDRL.
  • Subjects with IUCD.
  • Secondary dysmenorrhea.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of pain, site of pain, intensity of pain are to be assessed by WaLIDD Scores.0th day, 5th day of 2 menstrual cycles during treatment and 5th day of 3rd cycle without treatment.
Secondary Outcome Measures
NameTimeMethod
To improve the lifestyle.3 months

Trial Locations

Locations (1)

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital

🇮🇳

Hassan, KARNATAKA, India

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital
🇮🇳Hassan, KARNATAKA, India
Dr Anuradha Subhas Shivanagudi
Principal investigator
7090093411
anuradhashivanagudi@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.